EMD-29881

Single-particle
4.46 Å
EMD-29881 Deposition: 22/02/2023
Map released: 19/04/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-29881

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8g9x summary report (pdf.gz) Map-8g9x FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2)

EMD-29881

Single-particle
4.46 Å
EMD-29881 Deposition: 22/02/2023
Map released: 19/04/2023
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human immunodeficiency virus 1, Mus musculus
Sample: vFP49.02 Fab in complex with BG505 DS-SOSIP.664
Fitted models: 8g9x

Deposition Authors: Changela A, Gorman J , Kwong PD
Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
PUBMED: 37098956
DOI: doi:10.1128/jvi.01604-22
ISSN: 1098-5514
ASTM: JOVIAM